Monitoring antimalarial drug-resistance markers in Somalia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The use of an effective antimalarial drug is the cornerstone of malaria control. However, the development and spread of resistant Plasmodium falciparum strains have placed the global eradication of malaria in serious jeopardy. Molecular marker analysis constitutes the hallmark of the monitoring of Plasmodium drug-resistance. This study included 96 P. falciparum PCR-positive samples from southern Somalia. The P. falciparum chloroquine resistance transporter gene had high frequencies of K76T, A220S, Q271E, N326S, and R371I point mutations. The N86Y and Y184F mutant alleles of the P. falciparum multidrug resistance 1 gene were present in 84.7 and 62.4% of the isolates, respectively. No mutation was found in the P. falciparum Kelch-13 gene. This study revealed that chloroquine resistance markers are present at high frequencies, while the parasite remains sensitive to artemisinin (ART). The continuous monitoring of ART-resistant markers and in vitro susceptibility testing are strongly recommended to track resistant strains in real time.
Abstract
The use of an effective antimalarial drug is the cornerstone of malaria control. However, the development and spread of resistant Plasmodium falciparum strains have placed the global eradication of malaria in serious jeopardy. Molecular marker analysis constitutes the hallmark of the monitoring of Plasmodium drug-resistance. This study included 96 P. falciparum PCR-positive samples from southern Somalia. The P. falciparum chloroquine resistance transporter gene had high frequencies of K76T, A220S, Q271E, N326S, and R371I point mutations. The N86Y and Y184F mutant alleles of the P. falciparum multidrug resistance 1 gene were present in 84.7 and 62.4% of the isolates, respectively. No mutation was found in the P. falciparum Kelch-13 gene. This study revealed that chloroquine resistance markers are present at high frequencies, while the parasite remains sensitive to artemisinin (ART). The continuous monitoring of ART-resistant markers and in vitro susceptibility testing are strongly recommended to track resistant strains in real time.
참고문헌 (19)
- Bousema T, "Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination", Clin Microbiol Rev, 24(2), pp.377~410 (2011)[DOI]
- Jalei AA, "Plasmodium falciparum drug resistance gene status in the Horn of Africa : a systematic review", Afr J Pharm Pharmacol, 12(25), pp.361~373 (2018)[DOI]
- "Guidelines for the Treatment of Malaria" (2015)[URL]
- Warsame M, "Efficacy of monotherapies and artesunate-based combination therapies in children with uncomplicated malaria in Somalia", Acta Trop, 109(2), pp.146~151 (2009)[DOI]
- Warsame M, "Efficacy of artesunate+ sulphadoxine", pyrimethamine and artemether+ lumefantrine and dhfr and dhps mutations in Somalia : evidence for updating the malaria treatment policy, 2017, pp.22(4), 415~422
- Ariey F, "A molecular marker of artemisinin-resistant Plasmodium falciparum malaria", Nature, 505(7481), pp.50~55 (2014)[DOI]
- Ndwiga L, "A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa", Int J Parasitol Drugs Drug Resist, 16, pp.155~161 (2021)[DOI]
- Djimdé A, "A molecular marker for chloroquine-resistant falciparum malaria", N Engl J Med, 344(4), pp.257~263 (2001)[DOI]
- Jambou R, "Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6", Lancet, 366(9501), pp.1960~1963 (2005)[DOI]
- Win AA, "K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar", Malar J, 15, pp.1~7 (2016)[DOI]
- Nsanzabana C, "Molecular assays for antimalarial drug resistance surveillance : a target product profile", PLoS One, 13(9), pp.e0204347~ (2018)[DOI]
- Shafik SH, "The natural function of the malaria parasite’s chloroquine resistance transporter", Nat commun, 11(1), pp.1~16 (2020)[DOI]
- Durrand V, "Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter(Pfcrt)and their relationship to chloroquine resistance in vitro", Mol Biochem Parasitol, 136(2), pp.273~285 (2004)[DOI]
- Mwai L, "Chloroquine resistance before and after its withdrawal in Kenya", Malar J, 8, pp.1~10 (2009)[DOI]
- Ikegbunam MN, "Analysis of Plasmodium falciparum Pfcrt and Pfmdr1 genes in parasite isolates from asymptomatic individuals in Southeast Nigeria 11 years after withdrawal of chloroquine", Malar J, 18(1), pp.1~7 (2019)[DOI]
- Veiga MI, "Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies", Nat Commun, 7, pp.1~12 (2016)[DOI]
- Kavishe RA, "Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania", Malar J, 13, pp.1~6 (2014)[DOI]
- Ngalah BS, "Analysis of major genome loci underlying artemisinin resistance and pfmdr1 copy number in pre-and post-ACTs in western Kenya", Sci Rep, 5, pp.1~6 (2015)[DOI]
- Muwanguzi J, "Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children", Malar J, 15, pp.1~6 (2016)[DOI]